The level of IL-6, one of the major Th17-promoting cytokines, was significantly elevated in GBM compared to low-grade gliomas, while a higher level of IL-6 in CSF was associated with high infiltration of tumor-associated macrophages and poor prognosis in patients with GBM [61]. Here, IL6 is linked to glioblastoma.